Evidence map›Paper›PMID 31944650›Full record

ArticleACS applied materials & interfaces2020

Inhibition of

Humberto H Lara, Liliana Ixtepan-Turrent, Miguel Jose Yacaman, Jose Lopez-Ribot

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Morphotype-specific susceptibility toMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Fungal Biofilm: An Overview of the Latest Nano-Strategies.Antibiotics (Basel, Switzerland) · 2025
    Review
  11. Current Overview of Environmental Disinfection and Decolonization ofTropical medicine and infectious disease · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Current Perspectives of Antifungal Therapy: A Special Focus onJournal of fungi (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Humberto H LaraDepartment of Biology and South Texas Center for Emerging Infectious Diseases , The University of Texas at San Antonio, San Antonio, Texas 78249, United States.ORCID http://orcid.org/0000-0003-4854-9839
Liliana Ixtepan-TurrentDepartamento de Ciencias Basicas, Division de Ciencia de la Salud, Universidad de Monterrey, San Pedro Garza García, Nuevo León 66238, México.
Miguel Jose YacamanDepartment of Applied Physics and Materials Science, Northern Arizona University, 700 South Osborne Drive, Flagstaff, Arizona 86011, United States.
Jose Lopez-RibotDepartment of Biology and South Texas Center for Emerging Infectious Diseases , The University of Texas at San Antonio, San Antonio, Texas 78249, United States.
Texas Center for Infectious Disease · USNorthern Arizona University · USUniversity of Monterrey · MX

Funding

Development of novel chemical series of Candida albicans biofilm inhibitorsR01AI119554 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L., MCHARDY, STANTON FURST · 2015 to 2019
$1.8M
Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI119554NIDCR NIH HHS R01 DE023510
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsBandagesBiofilmsCandidaDisinfectantsElastomersMetal NanoparticlesMicrobial Sensitivity TestsSiliconesSilverTextilesAntifungal AgentsDisinfectantsElastomersSiliconesSilverbandagesbiofilmsCandida aurisfunctionalized surfacessilicone elastomersilver nanoparticles

Identifiers

PMID31944650
PMCPMC8243355
OpenAlexW2999173262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.